Basal cell carcinoma

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 5, Issue 6, 2005, Pages 551-554

  Brocke, Rebecca C C ^a  

^a HOPE HOSPITAL   (United Kingdom)

Author keywords

Basal cell carcinoma; Genodermatoses; Gorlin's syndrome; Mohs' micrographic surgery; Non melanoma skin cancer; Photodynamic therapy

Indexed keywords

ARSENIC; FLUOROURACIL; IMIQUIMOD; PSORALEN;

BASAL CELL CARCINOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SUSCEPTIBILITY; CHEMOSURGERY; CREAM; DIETARY INTAKE; DRUG FORMULATION; FAMILY HISTORY; FAT INTAKE; GENODERMATOSIS; HUMAN; IONIZING RADIATION; OCCUPATIONAL EXPOSURE; PATHOGENESIS; PHENOTYPE; PHOTODYNAMIC THERAPY; PROGNOSIS; PSORIASIS; PUVA; RADIATION EXPOSURE; REVIEW; RISK FACTOR; SIDE EFFECT; SKIN CARCINOGENESIS; SKIN CARCINOMA; SOLAR RADIATION; SUNBURN; TREATMENT FAILURE; VITAMIN INTAKE;

EID: 29244487864     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.5-6-551     Document Type: Review

References (15)

1. Karagas MR, Greenberg ER. Unresolved issues in the epidemiology of basal cell and squamous cell skin cancer. In: Mukhtar H (ed). Skin cancer. Mechanisms and human relevance. Boca Raton, Fl: CRC Press, 1995: 79-86.
2. Holme SA, Malinovszky K, Roberts DL. Changing trends in non-melanoma skin cancer in South Wales, 1988-98. Br J Dermatol 2000;143:1224-9.
3. Marks R, Staples M, Giles GG. Trends in non-melanocytic skin cancer treated in Australia: the second national survey, Int J Cancer 1993;53:585-90.
4. Wong CS, Strange RC, Lear JT. Basal cell carcinoma. Review. BMJ 2003;327:794-8.
5. Hartevelt MM, Bavinck JN, Kootte AM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 1990;49: 506-9.
6. Ramachandran S, Fryer AA, Smith AG, Lear JT et al. Basal cell carcinoma. Cancer 2000; 89:1012-8.
7. Ramachandran S, Lear JT, Ramsay H, Smith AG et al. Presentation with multiple cutaneous basal cell carcinomas: association of glutathione S-transferase and cytochrome P450 genotypes with clinical phenotype. Cancer Epidemiol Biomarkers Prev 1999;8:61-7.
8. Lear JT, Hoban P, Strange RC, Fryer AA. Basal cell carcinoma: from host response and polymorphic variants to tumour suppressor genes. Review. Clin Exp Dermatol 2005;30:49-55.
9. Lo JS, Snow SN, Reizner GT, Mohs FE et al. Metastatic basal cell carcinoma: report of twelve cases with a review of the literature. J Am Acad Dermatol 1991;24(5 Pt 1):715-9.
10. Telfer NR, Colver GB, Bowers PW. Guidelines for the management of basal cell carcinoma. British Association of Dermatologists. Br J Dermatol 1999;141: 415-23.
11. Breuninger H, Dietz K. Prediction of subclinical tumor infiltration in basal cell carcinoma. J Dermatol Surg Oncol 1991;17: 574-8.
12. Wolf DJ, Zitelli JA. Surgical margins for basal cell carcinoma. Arch Dermatol 1987; 123:340-4.
13. Rowe DE, Carroll RJ, Day CL Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. Review. J Dermatol Surg Oncol 1989;15:315-28.
14. Rowe DE, Carroll RJ, Day CL Jr. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989;15: 424-31.
15. Kuflik EG, Gage AA. The five-year cure rate achieved by cryosurgery for skin cancer. J Am Acad Dermatol 1991;24(6 Pt 1):1002-4.